Comparison of Biphozyl ® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation
Conditions: Critically Ill; Acute Kidney Injury; Renal Replacement Therapy; Continuous Renal Replacement Therapy; Continuous Veno-Venous Hemofiltration; Replacement Fluid; Phoxilium; Biphozyl; Anticoagulation; Regional Citrate Anticoagulation Interventions: Drug: CVVH with Phoxilium® in the first 48h after randomization; Drug: CVVH with Biphozyl® in the first 48h after randomization; Drug: CVVH with Phoxilium® in the second 48h after randomization (after previous 48h with Biphozyl®); Drug: CVVH with Biphozyl® in the second 48h after r andomization (after previous 48h with Phoxilium®) Sponsor: Medical University Innsbruck Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials